| 发明名称 |
OPHTHALMIC SUSPENSION COMPOSITION |
| 摘要 |
A suspension includes an ophthalmic active ingredient suspended in a formulation vehicle including a suspending agent and a non-ionic cellulose derivative. The ophthalmic active agent is present as particles having Dv90<5 μm and Dv50<1 μm. The suspension may be administered to a patient for treating an ophthalmic inflammatory condition. |
| 申请公布号 |
US2016213609(A1) |
申请公布日期 |
2016.07.28 |
| 申请号 |
US201615006525 |
申请日期 |
2016.01.26 |
| 申请人 |
Bausch & Lomb Incorporated |
发明人 |
Shawer Mohannad;Phillips Eric;Coffey Martin J. |
| 分类号 |
A61K9/00;A61K31/56;A61K31/573;A61K47/06;A61K47/32;A61K47/10;A61K47/02;A61K9/14;A61K47/38 |
主分类号 |
A61K9/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. An ophthalmic suspension comprising an ophthalmic active ingredient suspended in a formulation vehicle, wherein the ophthalmic active ingredient is present as particles that have Dv90<5 μm and Dv50<1 μm, and the formulation vehicle comprises a suspending agent and a non-ionic cellulose derivative. |
| 地址 |
Rochester NY US |
